Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix, Inc. (OCUL) is a healthcare company (biotechnology) based in the United States. The share price is $6.02, up 0.17% on the day, which values the company at $1.32B. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$6.02+0.17% today
Market value
$1.32B
Funk Score
40/100
Against its own history
Well below its usual priceusual price $9.33
200-week average
$7.8323% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Ocular Therapeutix, Inc. in more detail

OCUL trades at -3.8× next year's expected earnings, 26.3× sales. Measured against its own history, the price is 35% below what its usual multiples would imply ($9.33) — well below its usual price. It sits 23% below its 200-week average of $7.83.

Over the last five fiscal years Ocular Therapeutix, Inc. has compounded revenue 24.4% a year. Its Funk Score is 40 out of 100 (financial strength 4.9, profitability 0.0, growth 6.5, value 4.7, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Share count keeps rising; Thin interest cover.

Ocular Therapeutix, Inc. (OCUL): questions and answers

What is Ocular Therapeutix, Inc.'s market cap?

Ocular Therapeutix, Inc. is valued at $1.32B at a share price of $6.02.

Is OCUL overvalued or undervalued?

Against its own history, OCUL is well below its usual price: the price is 35% below the $9.33 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is OCUL above its 200-week moving average?

No. OCUL is 23.1% below its 200-week average of $7.83. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Ocular Therapeutix, Inc. growing?

Over the last five fiscal years Ocular Therapeutix, Inc.'s revenue grew 24.4% a year; over ten years revenue grew 40.4% a year.

Does OCUL pay a dividend?

Ocular Therapeutix, Inc. does not currently pay a regular dividend.

When does Ocular Therapeutix, Inc. report earnings next?

Ocular Therapeutix, Inc.'s next earnings report is expected on February 4, 2027. The date comes from the market data feed and companies do move it.

Cite this page

Funkfolio, “Ocular Therapeutix, Inc. (OCUL) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/OCUL

Underlying data: Yahoo Finance; company filings with the SEC.